Openbookopenbook
Equity
Primemd Inc(PRMD)
USD --+0.00%
Reward74High
Risk25Low
📊75%Data
Thin -117% profit margin · Revenue down 58% YoY
PRMD
+0.0 · +0.00%
USD · PINK
Primemd Inc | Healthcare
Quality Compounder
Market Cap:12949
ℹ️
Reward Rating
74
High
Top 10% (model universe)
75% data coverage
ℹ️
Risk Rating
25
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PRMD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Primemd Inc?

, together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States.

PRMD · Verdict

Strong reward · low risk

PRMD scores well on cash flow and growth with no major weaknesses flagged in the model.

Based on 88% data coverage

PRMD · Verdict

What’s working & what to watch

Strengths 6

  • Cash flow95/100

    21% free-cash-flow margin

  • Growth89/100

    Revenue +484.3% CAGR

  • Profitability75/100

    30% net margin · -7% ROE

  • Balance sheet75/100

    Interest covered 16.6×

  • Volatility75/100

    Above average

  • Valuation70/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Primemd Inc?

, together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. It also holds interests in oil and gas properties. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 12.95K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: High (74)

The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap12.95K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0007
52 Week Low0.0003
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding18M
No. of Employees1
IndustryMedical Care Facilities
ExchangePINK
Beta-7.42
CurrencyUSD
WebsiteN/A
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.